Ensysce Stock Analysis

ENSC -  USA Stock  

USD 5.34  0.10  1.84%

The big decline in price over the last few months for Ensysce Biosciences could raise concerns from investors as the firm it trading at a share price of 5.34 on 1,219,323 in volume. The company management teams failed to add value to investors and positioning the firm supply of money to exploit market volatility in July. However, diversifying your holdings with Ensysce Biosciences or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 5.72. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Ensysce Biosciences partners.
Continue to Investing Opportunities.

Search Stock Analysis 

 
Refresh
The Ensysce Biosciences stock analysis report makes it easy to digest most publicly released information about Ensysce Biosciences and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Ensysce Stock analysis module also helps to analyze the Ensysce Biosciences price relationship with some important fundamental indicators such as market cap and management efficiency.

Ensysce Stock Analysis Notes

The company had not issued any dividends in recent years.

Ensysce Biosciences Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Ensysce Biosciences' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Ensysce Biosciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Ensysce Biosciences generates negative expected return over the last 90 days
Ensysce Biosciences has high historical volatility and very poor performance
Ensysce Biosciences has high likelihood to experience some financial distress in the next 2 years
Ensysce Biosciences has a poor financial position based on the latest SEC disclosures
Latest headline from www.equities.com: Ensysce Bio drops 11.04 percent to Close at 5.56 on July 29 - Equities.com

Ensysce Biosciences Upcoming and Recent Events

Earnings reports are used by Ensysce Biosciences to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Ensysce Biosciences previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report6th of August 2021
Next Fiscal Quarter End30th of June 2021

Ensysce Biosciences SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Ensysce Biosciences prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Ensysce Biosciences investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Ensysce Biosciences specific information freely available to individual and institutional investors to make a timely investment decision.
21st of July 2021
Financial Statements and Exhibits. Regulation FD Disclosure
View
12th of July 2021
Unclassified Corporate Event
View
8th of July 2021
Financial Statements and Exhibits. Regulation FD Disclosure
View
6th of July 2021
Unclassified Corporate Event
View
1st of July 2021
Financial Statements and Exhibits. Other Events. Regulation FD Disclosure
View
29th of June 2021
Submission of Matters to a Vote of Security Holders
View
11th of June 2021
Unregistered Sales of Equity Securities. Entry into a Material Definitive Agreement
View
1st of June 2021
Financial Statements and Exhibits. Regulation FD Disclosure. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
View

Ensysce Biosciences Thematic Classifications

In addition to having Ensysce Biosciences stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Pharmaceutical Products IdeaPharmaceutical Products
USA Equities from Pharmaceutical Products industry as classified by Fama & French

Ensysce Profitablity

Ensysce Biosciences' profitability indicators refer to fundamental financial ratios that showcase Ensysce Biosciences' ability to generate income relative to its revenue or operating costs. If, let's say, Ensysce Biosciences is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Ensysce Biosciences' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Ensysce Biosciences' profitability requires more research than a typical breakdown of Ensysce Biosciences' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2021
Return on Average Assets 0.003  0.003237 
Return on Average Equity 0.027  0.0292 
Return on Invested Capital 0.05  0.06 
Return on Sales 0.27  0.29 

Management Efficiency

The current year Return on Average Assets is expected to grow to 0.003237. The current year Return on Average Equity is expected to grow to 0.0292. Ensysce Biosciences Total Assets are projected to decrease significantly based on the last few years of reporting. The past year's Total Assets were at 351,807. The current year Current Assets is expected to grow to about 357 K, whereas Tax Assets are forecasted to decline to about 152.6 K. Ensysce Biosciences management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for 2021
Book Value per Share(0.61) (0.63) 
Enterprise Value over EBIT 74.00  79.84 
Enterprise Value over EBITDA 74.47  80.36 
Price to Book Value(12.09) (12.41) 
Tangible Assets Book Value per Share 0.033  0.0339 
Enterprise Value78.4 M80.4 M
Tangible Asset Value351.8 K361.1 K

Technical Drivers

As of the 3rd of August, Ensysce Biosciences shows the coefficient of variation of (236.28), and Mean Deviation of 3.46. Ensysce Biosciences technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We are able to interpolate and collect nineteen technical drivers for Ensysce Biosciences, which can be compared to its rivals. Please confirm Ensysce Biosciences variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and semi variance to decide if Ensysce Biosciences is priced favorably, providing market reflects its regular price of 5.34 per share. Given that Ensysce Biosciences has jensen alpha of (2.06), we urge you to verify Ensysce Biosciences's prevailing market performance to make sure the company can sustain itself at a future point.

Ensysce Biosciences Price Movement Analysis

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Moving Average is predictive technique used to analyze Ensysce Biosciences price data points by creating a series of averages of different subsets of Ensysce Biosciences entire price series. View also all equity analysis or get more info about all moving average overlap studies indicator.

Ensysce Biosciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Ensysce Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Ensysce Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Ensysce Biosciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Ensysce Biosciences Predictive Daily Indicators

Ensysce Biosciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Ensysce Biosciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Ensysce Biosciences Forecast Models

Ensysce Biosciences time-series forecasting models is one of many Ensysce Biosciences' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Ensysce Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Ensysce Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Ensysce Biosciences stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Ensysce shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Ensysce Biosciences. By using and applying Ensysce Stock analysis, traders can create a robust methodology for identifying Ensysce entry and exit points for their positions.
Last ReportedProjected for 2021
EBITDA Margin 0.27  0.29 
Gross Margin 0.90  0.89 
Profit Margin 0.014  0.0151 

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Ensysce Biosciences to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Fundamentals Comparison Now

   

Fundamentals Comparison

Compare fundamentals across multiple equities to find investing opportunities
All  Next Launch Module
Continue to Investing Opportunities. Note that the Ensysce Biosciences information on this page should be used as a complementary analysis to other Ensysce Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Complementary Tools for Ensysce Stock analysis

When running Ensysce Biosciences price analysis, check to measure Ensysce Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ensysce Biosciences is operating at the current time. Most of Ensysce Biosciences' value examination focuses on studying past and present price action to predict the probability of Ensysce Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Ensysce Biosciences' price. Additionally, you may evaluate how the addition of Ensysce Biosciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
The market value of Ensysce Biosciences is measured differently than its book value, which is the value of Ensysce that is recorded on the company's balance sheet. Investors also form their own opinion of Ensysce Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Ensysce Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ensysce Biosciences' market value can be influenced by many factors that don't directly affect Ensysce Biosciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ensysce Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Ensysce Biosciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ensysce Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.